Curated Information
Javascript is not enabled on this browser. This site will not work properly without Javascript.
PhosphoSitePlus Homepage PhosphoSitePlus® v6.5.9
Powered by Cell Signaling Technology
Home > Curated Information Page > Cst Curation Set #5429
Zhou J (2008) CST Curation Set: 5429; Year: 2008; Biosample/Treatment: cell line, HeLa/nocodazole; Disease: cervical adenocarcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: p[ST]P Antibodies Used to Purify Peptides prior to LCMS: Phospho-(Ser) CDKs Substrate Antibody Cat#: 2324, PTMScan(R) Phospho-CDK Substrate Motif (K/RS*PXK/R) Immunoaffinity Beads Cat#: 1981
This page summarizes selected information from the record referenced above and curated into PhosphoSitePlus®, a comprehensive online resource for the study of protein post-translational modifications (NAR, 2015, 43:D512-20). To learn more about the scope of PhosphoSitePlus®, click here.
Click on the protein name to open the protein page, and on the RSD number to open the site page.
Download

S257-p - ARHGEF7 (human)
Modsite: PKsGtLKsPPKGFDt SwissProt Entrez-Gene
Orthologous residues
ARHGEF7 (human): S257‑p, ARHGEF7 iso1 (human): S79‑p, ARHGEF7 (mouse): S236‑p, ARHGEF7 iso2 (mouse): S236‑p, ARHGEF7 iso3 (mouse): S236‑p, ARHGEF7 (rat): S79‑p, ARHGEF7 (cow): S207‑p
Characterization
Methods used to characterize site in vivo mass spectrometry
Relevant cell lines - cell types - tissues:  HeLa (cervical)

S289-p - BRD7 (human)
Modsite: AEAHAFKsPsKENKK SwissProt Entrez-Gene
Orthologous residues
BRD7 (human): S289‑p, BRD7 iso2 (human): S289‑p, BRD7 (mouse): S289‑p, BRD7 (rat): S43‑p
Characterization
Methods used to characterize site in vivo mass spectrometry
Relevant cell lines - cell types - tissues:  HeLa (cervical)

S201-p - CDYL (human)
Modsite: IKILVPKsPVKSRtA SwissProt Entrez-Gene
Orthologous residues
CDYL (human): S201‑p, CDYL iso2 (human): S147‑p, CDYL (mouse): S196‑p, CDYL (rat): S195‑p
Characterization
Methods used to characterize site in vivo mass spectrometry
Relevant cell lines - cell types - tissues:  HeLa (cervical)

S1677-p - CHD-1 (human)
Modsite: AsssGPRsPLDQRsP SwissProt Entrez-Gene
Orthologous residues
CHD‑1 (human): S1677‑p, CHD‑1 iso2 (human): S1677‑p, CHD‑1 (mouse): S1678‑p, CHD‑1 (rat): S1678‑p
Characterization
Methods used to characterize site in vivo mass spectrometry
Relevant cell lines - cell types - tissues:  HeLa (cervical)
Species studied:  human

S1683-p - CHD-1 (human)
Modsite: RsPLDQRsPyGsRsP SwissProt Entrez-Gene
Orthologous residues
CHD‑1 (human): S1683‑p, CHD‑1 iso2 (human): S1683‑p, CHD‑1 (mouse): S1684‑p, CHD‑1 (rat): S1684‑p
Characterization
Methods used to characterize site in vivo mass spectrometry
Relevant cell lines - cell types - tissues:  HeLa (cervical)
Species studied:  human

S209-p - CK2B (human)
Modsite: QAAsNFksPVktIR_ SwissProt Entrez-Gene
Orthologous residues
CK2B (human): S209‑p, CK2B (mouse): S209‑p, CK2B (rat): S209‑p, CK2B (chicken): S209‑p
Characterization
Methods used to characterize site in vivo mass spectrometry
Relevant cell lines - cell types - tissues:  HeLa (cervical)

S468-p - COPS1 (human)
Modsite: RNQIHVksPPREGsQ SwissProt Entrez-Gene
Orthologous residues
COPS1 (human): S468‑p, COPS1 iso3 (human): S453‑p, COPS1 iso5 (human): S464‑p, COPS1 (mouse): S448‑p, COPS1 iso4 (mouse): S503‑p, COPS1 (rat): S448‑p
Characterization
Methods used to characterize site in vivo mass spectrometry
Relevant cell lines - cell types - tissues:  HeLa (cervical)

S1533-p - FLNA (human)
Modsite: GDEEVPRsPFKVkVL SwissProt Entrez-Gene
Orthologous residues
FLNA (human): S1533‑p, FLNA iso2 (human): S1533‑p, FLNA (mouse): S1533‑p, FLNA (rat): S1533‑p, FLNA (cow): S1536‑p
Characterization
Methods used to characterize site in vivo mass spectrometry
Relevant cell lines - cell types - tissues:  HeLa (cervical)

S1505-p - FLNB (human)
Modsite: ADEEIPRsPFkVKVL SwissProt Entrez-Gene
Orthologous residues
FLNB (human): S1505‑p, FLNB iso2 (human): S1505‑p, FLNB iso8 (human): S1536‑p, FLNB (mouse): S1505‑p, FLNB (rat): S1505‑p, FLNB (cow): S1536‑p
Characterization
Methods used to characterize site in vivo mass spectrometry
Relevant cell lines - cell types - tissues:  HeLa (cervical)

S1031-p - FMNL1 (human)
Modsite: GEPPAPKsPPKARRP SwissProt Entrez-Gene
Orthologous residues
FMNL1 (human): S1031‑p, FMNL1 iso2 (human): S1031‑p, FMNL1 (mouse): S1021‑p, FMNL1 iso2 (mouse): S995‑p, FMNL1 (rat): S965‑p
Characterization
Methods used to characterize site in vivo mass spectrometry
Relevant cell lines - cell types - tissues:  HeLa (cervical)

T115-p - MFF (human)
Modsite: FkPLALktPPRVLtL SwissProt Entrez-Gene
Orthologous residues
MFF (human): T115‑p, MFF iso2 (human): T89‑p, MFF iso4 (human): T89‑p, MFF iso5 (human): T89‑p, MFF (mouse): T89‑p, MFF iso2 (mouse): T89‑p, MFF iso4 (mouse): T89‑p, MFF (rat): T115‑p
Characterization
Methods used to characterize site in vivo mass spectrometry
Relevant cell lines - cell types - tissues:  HeLa (cervical)

T89-p - MFF iso2 (human)
Modsite: FKPLALKtPPRVLTL SwissProt Entrez-Gene
Orthologous residues
MFF (human): T115‑p, MFF iso2 (human): T89‑p, MFF iso4 (human): T89‑p, MFF iso5 (human): T89‑p, MFF (mouse): T89‑p, MFF iso2 (mouse): T89‑p, MFF iso4 (mouse): T89‑p, MFF (rat): T115‑p
Characterization
Methods used to characterize site in vivo mass spectrometry
Relevant cell lines - cell types - tissues:  HeLa (cervical)

T89-p - MFF iso5 (human)
Modsite: FKPLALKtPPRVLTL SwissProt Entrez-Gene
Orthologous residues
MFF (human): T115‑p, MFF iso2 (human): T89‑p, MFF iso4 (human): T89‑p, MFF iso5 (human): T89‑p, MFF (mouse): T89‑p, MFF iso2 (mouse): T89‑p, MFF iso4 (mouse): T89‑p, MFF (rat): T115‑p
Characterization
Methods used to characterize site in vivo mass spectrometry
Relevant cell lines - cell types - tissues:  HeLa (cervical)

S1925-p - MYO9B (human)
Modsite: WPLKLGFssPyEGVL SwissProt Entrez-Gene
Orthologous residues
MYO9B (human): S1925‑p, MYO9B iso2 (human): S1925‑p, MYO9B (mouse): S1883‑p, MYO9B iso3 (mouse): , MYO9B iso5 (mouse): S1897‑p, MYO9B (rat): S1885‑p, MYO9B (cow): S1924‑p
Characterization
Methods used to characterize site in vivo mass spectrometry
Relevant cell lines - cell types - tissues:  HeLa (cervical)
Species studied:  human

S1935-p - MYO9B (human)
Modsite: yEGVLNKsPKTRDIQ SwissProt Entrez-Gene
Orthologous residues
MYO9B (human): S1935‑p, MYO9B iso2 (human): S1935‑p, MYO9B (mouse): S1893‑p, MYO9B iso3 (mouse): S1877‑p, MYO9B iso5 (mouse): S1907‑p, MYO9B (rat): S1895‑p, MYO9B (cow): N1934‑p
Characterization
Methods used to characterize site in vivo mass spectrometry
Relevant cell lines - cell types - tissues:  HeLa (cervical)
Species studied:  human

T799-p - RANBP2 (human)
Modsite: syKysPktPPRWAED SwissProt Entrez-Gene
Orthologous residues
RANBP2 (human): T799‑p, RANBP2 (mouse): T799‑p, RANBP2 (rat): T799‑p, RANBP2 (cow): T799‑p
Characterization
Methods used to characterize site in vivo mass spectrometry
Relevant cell lines - cell types - tissues:  HeLa (cervical)

S741-p - RBM15 (human)
Modsite: tAPtEGKsPLKKEDR SwissProt Entrez-Gene
Orthologous residues
RBM15 (human): S741‑p, RBM15 iso2 (human): S741‑p, RBM15 iso3 (human): S741‑p, RBM15 (mouse): N742‑p, RBM15 (rat): T742‑p
Characterization
Methods used to characterize site in vivo mass spectrometry
Relevant cell lines - cell types - tissues:  HeLa (cervical)

T800-p - RGPD3 (human)
Modsite: syKysPktPPRWAED SwissProt Entrez-Gene
Orthologous residues
RGPD3 (human): T800‑p
Characterization
Methods used to characterize site in vivo mass spectrometry
Relevant cell lines - cell types - tissues:  HeLa (cervical)

S758-p - ZNF609 (human)
Modsite: CRAEEGKsPFREssG SwissProt Entrez-Gene
Orthologous residues
ZNF609 (human): S758‑p, ZNF609 (mouse): S757‑p, ZNF609 (rat): S758‑p
Characterization
Methods used to characterize site in vivo mass spectrometry
Relevant cell lines - cell types - tissues:  HeLa (cervical)